Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Esposito joins Phadia

This article was originally published in Clinica

Executive Summary

Swedish allergy testing specialist Phadia has appointed David Esposito senior vice-president of US sales and marketing. Mr Esposito previously worked for Merck for 16 years, where he was most recently executive director for the respiratory marketing team. He will now help expand marketing efforts to increase awareness of Uppsala-based Phadia's ImmunoCAP Specific IgE blood test in the US. The diagnostic helps doctors to diagnose allergic triggers that underlie a patient's asthma, rhinitis or eczema.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044041

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel